The product was found to contain Rhizopus oryzae, which may cause health problems to consumers, particularly premature infants/infants, children, and those with weakened immune systems.
FDA believes the benefits of clopidogrel (Plavix) and prasugrel (Effient) therapy continue to outweigh their potential risks when used for approved uses.
There is the possibility of fungal infection should patients come in contact with the mold.
Risk of impaired ability to fight infections, high blood sugar levels, muscle injuries, and psychiatric problems.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti
informazioni sui medicinali, biocidi, e dispositivi medici contenenti clorexidina in soluzione cutanea per uso cutaneo nei neonati.
Ventilator may stop working after the air and oxygen gas supply lines are disconnected and then reconnected. This can lead to serious health problems or death.
80.211.154.110
